Why is Cachet Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -2.49% and Operating profit at -19.21% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 12.08% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -2.49% and Operating profit at -19.21% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY 95.19 MM has Grown at -38.76%
- ROCE(HY) Lowest at 1.61%
- RAW MATERIAL COST(Y) Grown by 7.31% (YoY)
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cachet Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Cachet Pharmaceutical Co., Ltd.
5.6%
0.43
41.08%
China Shanghai Composite
13.33%
0.90
14.74%
Quality key factors
Factor
Value
Sales Growth (5y)
-2.49%
EBIT Growth (5y)
-19.21%
EBIT to Interest (avg)
5.19
Debt to EBITDA (avg)
1.78
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
3.27
Tax Ratio
43.90%
Dividend Payout Ratio
30.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.34%
ROE (avg)
12.08%
Valuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
0.94
EV to EBIT
10.65
EV to EBITDA
8.99
EV to Capital Employed
0.94
EV to Sales
0.22
PEG Ratio
NA
Dividend Yield
1.21%
ROCE (Latest)
8.84%
ROE (Latest)
5.28%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Technical Movement
2What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 4.47 %
-18What is not working for the Company
NET PROFIT(HY)
At CNY 95.19 MM has Grown at -38.76%
ROCE(HY)
Lowest at 1.61%
RAW MATERIAL COST(Y)
Grown by 7.31% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.02 times
NET SALES(Q)
At CNY 4,759.15 MM has Fallen at -8.78%
PRE-TAX PROFIT(Q)
At CNY 61.04 MM has Fallen at -38.92%
Here's what is working for Cachet Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Lowest at 4.47 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Cachet Pharmaceutical Co., Ltd.
Net Profit
At CNY 95.19 MM has Grown at -38.76%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 4,759.15 MM has Fallen at -8.78%
over average net sales of the previous four periods of CNY 5,217.5 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 61.04 MM has Fallen at -38.92%
over average net sales of the previous four periods of CNY 99.93 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 7.02 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 7.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






